Global Health [MEDANTA] vs Aster DM Healthcare [ASTERDM] Detailed Stock Comparison
TLDR: Quick Comparison Summary
Based on 20 vital metrics comparison: Global Health Ltd. wins in 11 metrics, Aster DM Healthcare Ltd. wins in 9 metrics, with 0 ties. Global Health Ltd. appears stronger overall.
View Metrics Details
Vital Metrics Comparison
| Metric | Global Health Ltd. | Aster DM Healthcare Ltd. | Better |
|---|---|---|---|
| P/E Ratio (TTM) | 58.23 | 110.37 | Global Health Ltd. |
| Price-to-Book Ratio | 8.08 | 8.03 | Aster DM Healthcare Ltd. |
| Debt-to-Equity Ratio | 25.47 | 43.79 | Global Health Ltd. |
| PEG Ratio | -1.74 | -2.33 | Global Health Ltd. |
| EV/EBITDA | 33.65 | 46.61 | Global Health Ltd. |
| Profit Margin (TTM) | 12.29% | 7.33% | Global Health Ltd. |
| Operating Margin (TTM) | 13.93% | 12.11% | Global Health Ltd. |
| EBITDA Margin (TTM) | 13.93% | 12.11% | Global Health Ltd. |
| Return on Equity | 14.21% | 147.28% | Aster DM Healthcare Ltd. |
| Return on Assets (TTM) | 10.10% | 81.40% | Aster DM Healthcare Ltd. |
| Free Cash Flow (TTM) | $-241.56M | $683.20M | Aster DM Healthcare Ltd. |
| Dividend Yield | 0.04% | 1.05% | Aster DM Healthcare Ltd. |
| 1-Year Return | 4.14% | 43.05% | Aster DM Healthcare Ltd. |
| Price-to-Sales Ratio (TTM) | 7.15 | 8.17 | Global Health Ltd. |
| Enterprise Value | $295.72B | $373.17B | Aster DM Healthcare Ltd. |
| EV/Revenue Ratio | 7.07 | 8.37 | Global Health Ltd. |
| Gross Profit Margin (TTM) | 77.19% | 77.44% | Aster DM Healthcare Ltd. |
| Revenue per Share (TTM) | $156 | $87 | Global Health Ltd. |
| Earnings per Share (Diluted) | $19.12 | $6.39 | Global Health Ltd. |
| Beta (Stock Volatility) | -0.02 | -0.06 | Aster DM Healthcare Ltd. |
Global Health Ltd. vs Aster DM Healthcare Ltd. Stock Performance Analysis
Loading Price Chart...
Performance Comparison
Short-term Returns
| Stock | 1D | 1W | 1M | 3M | 6M | YTD |
|---|---|---|---|---|---|---|
| Global Health Ltd. | -1.23% | 0.78% | -1.82% | 17.21% | 6.24% | 2.35% |
| Aster DM Healthcare Ltd. | -3.47% | 2.68% | 4.39% | 21.18% | 27.32% | 29.67% |
Long-term Returns
| Stock | 1Y | 3Y | 5Y | 10Y | 15Y | 20Y |
|---|---|---|---|---|---|---|
| Global Health Ltd. | 4.14% | 90.43% | 198.23% | 198.23% | 198.23% | 198.23% |
| Aster DM Healthcare Ltd. | 43.05% | 181.55% | 407.76% | 372.16% | 372.16% | 372.16% |
Performance & Financial Health Analysis: Global Health Ltd. vs Aster DM Healthcare Ltd.
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Market Information | ||
| Market Cap | ₹298.62B | ₹364.57B |
| Market Cap Category | Large cap | Large cap |
| 10 Day Avg. Volume | 163,931 | 556,447 |
| 90 Day Avg. Volume | 207,501 | 656,240 |
| Last Close | ₹1,219.90 | ₹786.70 |
| 52 Week Range | ₹956.00 - ₹1,456.50 | ₹519.10 - ₹836.50 |
| % from 52W High | -16.24% | -5.95% |
| All-Time High | ₹1,513.90 (Feb 12, 2024) | ₹836.50 (Jun 12, 2026) |
| % from All-Time High | -19.42% | -5.95% |
| Growth Metrics | ||
| Quarterly Revenue Growth | 0.19% | 0.13% |
| Quarterly Earnings Growth | -0.34% | -0.08% |
| Financial Health | ||
| Profit Margin (TTM) | 0.12% | 0.07% |
| Operating Margin (TTM) | 0.14% | 0.12% |
| Return on Equity (TTM) | 0.14% | 1.47% |
| Debt to Equity (MRQ) | 25.47 | 43.79 |
| Cash & Liquidity | ||
| Book Value per Share (MRQ) | ₹137.83 | ₹87.77 |
| Cash per Share (MRQ) | ₹45.46 | ₹24.81 |
| Operating Cash Flow (TTM) | ₹5.45B | ₹54.10B |
| Levered Free Cash Flow (TTM) | ₹4.81B | ₹53.78B |
| Dividends | ||
| Last 12-Month Dividend Yield | 0.04% | 1.05% |
| Last 12-Month Dividend | ₹0.50 | ₹6.00 |
Valuation & Enterprise Metrics Analysis: Global Health Ltd. vs Aster DM Healthcare Ltd.
| Metric | MEDANTA (Apr 24, 2026) | ASTERDM (Apr 26, 2026) |
|---|---|---|
| Price Ratios | ||
| P/E Ratio (TTM) | 58.23 | 110.37 |
| Forward P/E | 43.09 | 60.80 |
| PEG Ratio | -1.74 | -2.33 |
| Price to Sales (TTM) | 7.15 | 8.17 |
| Price to Book (MRQ) | 8.08 | 8.03 |
| Market Capitalization | ||
| Market Capitalization | ₹298.62B | ₹364.57B |
| Enterprise Value | ₹295.72B | ₹373.17B |
| Enterprise Value Metrics | ||
| Enterprise to Revenue | 7.07 | 8.37 |
| Enterprise to EBITDA | 33.65 | 46.61 |
| Risk & Other Metrics | ||
| Beta | -0.02 | -0.06 |
| Book Value per Share (MRQ) | ₹137.83 | ₹87.77 |
Financial Statements Comparison: Global Health Ltd. vs Aster DM Healthcare Ltd.
Financial Metrics
Loading Financial Charts...
Revenue
Operating Margin
Profit Margin
Long Term Debt
Income Flow Analysis
Financial Statements Comparison
Income Statement
| Metric | MEDANTA (2025) | ASTERDM (2025) |
|---|---|---|
| Revenue/Sales | 36.37B | 40.69B |
| Cost of Goods Sold | 8.80B | 9.38B |
| COGS % of Revenue | 24.2% | 23.1% |
| Gross Profit | 27.57B | 31.31B |
| Gross Margin | 75.8% | 76.9% |
| Research & Development | 4.14M | N/A |
| Operating Income (EBIT) | 7.37B | 5.25B |
| Operating Margin | 20.3% | 12.9% |
| EBITDA | 9.99B | 8.75B |
| EBITDA Margin | 27.5% | 21.5% |
| Pre-Tax Income | 6.47B | 4.71B |
| Pre-Tax Income % of Revenue | 17.8% | 11.6% |
| Income Tax | 1.66B | 1.34B |
| Income Tax % of Revenue | 4.6% | 3.3% |
| Net Income (Profit) | 4.81B | 54.08B |
| Profit Margin | 13.2% | 132.9% |
Balance Sheet & Liquidity Metrics
| Metric | MEDANTA (2025) | ASTERDM (2025) |
|---|---|---|
| Cash & Equivalents | 2.30B | 1.65B |
| Total Current Assets | 15.33B | 19.01B |
| Total Current Assets % of Revenue | 42.2% | 46.7% |
| Total Current Liabilities | 6.19B | 8.79B |
| Total Current Liabilities % of Revenue | 17.0% | 21.6% |
| Long-Term Debt | 6.24B | 18.29B |
| Long-Term Debt % of Revenue | 17.1% | 45.0% |
| Total Shareholders Equity | 33.88B | 36.51B |
| Retained Earnings | 22.48B | -1.52B |
| Retained Earnings % of Revenue | 61.8% | -3.7% |
| Property, Plant & Equipment | 15.13B | 12.75B |
Cash Flow Statement Comparison
| Metric | MEDANTA (2025) | ASTERDM (2025) |
|---|---|---|
| Operating Cash Flow | 5.45B | 54.10B |
| Operating Cash Flow % of Revenue | 15.0% | 132.9% |
| Capital Expenditures | -5.14B | -3.44B |
| Free Cash Flow | -241.56M | 683.20M |
| FCF Margin | -0.7% | 1.7% |
| Debt Repayment | -1.83B | -1.34B |
| Common Stock Repurchase | N/A | N/A |
Short Interest & Institutional Ownership Analysis
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Shares Short | N/A | N/A |
| Short Ratio | N/A | N/A |
| Short % of Float | N/A | N/A |
| Shares Outstanding | 268.70M | 516.94M |
| Float Shares | 87.05M | 191.44M |
| % Held by Insiders | 67.51% | 53.34% |
| % Held by Institutions | 21.68% | 31.94% |
| % Held by Public | 10.81% | 14.72% |
Dividend Analysis & Yield Comparison: Global Health Ltd. vs Aster DM Healthcare Ltd.
| Metric | MEDANTA | ASTERDM |
|---|---|---|
| Last 12-Month Dividend | ₹0.50 | ₹6.00 |
| Last 12-Month Dividend Yield | 0.04% | 1.05% |
| 3-Year Avg Annual Dividend | ₹0.17 | ₹41.33 |
| 3-Year Avg Dividend Yield | 0.04% | 11.45% |
| 3-Year Total Dividends | ₹0.50 | ₹124.00 |
| Ex-Dividend Date | Aug 22, 2025 | Feb 10, 2025 |